Stockscreener 앱 받기
14.14
0.78%
0.11
시장 영업 전:
13.81
-0.33
-2.33%
Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스
Brokers Set Expectations for RCUS FY2025 Earnings - MarketBeat
Financial Survey: Barinthus Biotherapeutics (NASDAQ:BRNS) & Arcus Biosciences (NYSE:RCUS) - Defense World
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer - BioSpace
Arcus Biosciences appoints new Chief Medical Officer - Investing.com
Arcus Biosciences appoints new Chief Medical Officer By Investing.com - Investing.com UK
Arcus Biosciences Announces New Chief Medical Officer - TipRanks
Arcus Biosciences, Inc. Announces Chief Medical Officer Changes -January 21, 2025 at 04:05 pm EST - Marketscreener.com
Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of "Buy" by Analysts - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of “Buy” by Analysts - Defense World
Wells Fargo Initiates Coverage of Arcus Biosciences (RCUS) with Overweight Recommendation - MSN
Undercovered Dozen: Lincoln National, Whitecap Resources, NMI Holdings, Healwell AI + - Seeking Alpha
How the (RCUS) price action is used to our Advantage - Stock Traders Daily
Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 - Seeking Alpha
Arcus Biosciences stock hits 52-week low at $13.51 By Investing.com - Investing.com Canada
Arcus Biosciences (NYSE:RCUS) Sets New 52-Week LowTime to Sell? - MarketBeat
Arcus: Excellent Pipeline And Collaborations, Cash Runway (NYSE:RCUS) - Seeking Alpha
Arcus Biosciences (NYSE:RCUS investor three-year losses grow to 60% as the stock sheds US$79m this past week - Simply Wall St
Robert C. Goeltz II Sells 3,594 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) Stock - MarketBeat
Principal Financial Group Inc. Sells 18,777 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Geode Capital Management LLC Has $18.69 Million Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Barclays PLC Grows Position in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Purchased by Barclays PLC - MarketBeat
(RCUS) Trading Report - Stock Traders Daily
Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Rating of “Buy” by Brokerages - Defense World
Arcus Biosciences Grants Stock Options, RSUs to New Employees Under Inducement Plan - StockTitan
Shareholders in Arcus Biosciences (NYSE:RCUS) have lost 65%, as stock drops 9.9% this past week - Yahoo Finance
Jane Street Group LLC Boosts Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
State Street Corp Lowers Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Arcus Biosciences to Present at J.P. Morgan Healthcare Conference 2025Key Oncology Updates Expected - StockTitan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 26,966 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
BNP Paribas Financial Markets Has $173,000 Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
(RCUS) Trading Advice - Stock Traders Daily
Arcus Biosciences' SWOT analysis: stock outlook amid HIF2alpha and TIGIT progress - Investing.com
Estimating The Intrinsic Value Of Arcus Biosciences, Inc. (NYSE:RCUS) - Simply Wall St
Charles Schwab Investment Management Inc. Has $8.67 Million Stock Position in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Arcus Biosciences Announces New Employment Inducement Grants - Marketscreener.com
Arcus Biosciences Awards New Employee Equity Grants Under Inducement Plan - StockTitan
Fmr LLC Boosts Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Point72 Asset Management L.P. Increases Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
(RCUS) Investment Analysis and Advice - Stock Traders Daily
Arcus Biosciences' chief accounting officer sells $3,079 in stock - Investing.com
Arcus Biosciences' chief accounting officer sells $3,079 in stock By Investing.com - Investing.com Canada
Parkman Healthcare Partners LLC Acquires 610,219 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Arcus Biosciences Grants New Employee Stock Options and RSUs in Latest Inducement Awards - StockTitan
Walleye Capital LLC Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend - Benzinga
Suvretta Capital Management LLC Trims Position in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Algert Global LLC Has $1.73 Million Position in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
Arcus up 4% following Merck Welireg kidney cancer data - MSN
When (RCUS) Moves Investors should Listen - Stock Traders Daily
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $14.24 Million Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - MarketBeat
RCUS (Arcus Biosciences) Cash-to-Debt : 18.78 (As of Sep. 2024) - GuruFocus.com
Arcus Biosciences, Inc.'s (NYSE:RCUS) Price Is Right But Growth Is Lacking - Simply Wall St
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2024 Earnings Call Transcript - MSN
4.81%
자본화:
|
볼륨(24시간):